Timeline of Purdue lawsuits

THANKS TO-Christine Minhee, OpioidSettlementTracker.com LLC.

Sackler family, the maker of OxyContin, will be shielded from lawsuits as part of $6B settlement

Josh Shapiro PA proud

Walmart offers to pay $3.1 billion to settle opioid lawsuits

The millennial generation of addicts alone could jump start the economy when returning to the workforce.  I believe having a solid plan and investing into the needs of treatment and recovery is needed to recover from this crisis, and a better Pennsylvania that other states could be inspired from.

There’s finally billions of dollars being paid out from the settlements of lawsuits. I hope you can consider sponsoring a bill or start a conversation into changing the future for addicts and the people that love them.  I believe they can recover but the journey will be long.  The money that is to be received in the lawsuits should be dedicated to the people that didn't last to see the change, and hopefully their lives can help change laws and reunite families.

The Sackler family owners of Purdue Pharma LP reached a deal with a group of attorneys general to pay up to $6 billion in cash to resolve widespread litigation alleging that they fueled the U.S. opioid epidemic, bringing the OxyContin maker closer to exiting bankruptcy.

The attorneys general for eight states and the District of Columbia, who had blocked a previous settlement that included a $4.3 billion cash payment, announced the deal after weeks of mediation with the Sacklers.

Pennsylvania attorney general sues family who owns Purdue Pharma over its role in the opioid crisis

“Through our negotiations with Purdue Pharma, it became crystal clear the Sacklers have no intention of taking any ownership for engineering an epidemic that claims the lives of 12 Pennsylvanians each day,” Shapiro said in a release Thursday morning. He wrote that his lawsuit would “require this family of billionaires” to “take responsibility for the pain they caused.”

CVS, Walgreens and Walmart are the three largest retail pharmacies in the country by market share. If their settlement becomes final, it will put much of the sprawling, years-long litigation over opioids to rest, though cases are still pending against smaller, more regionally focused pharmacy operators including Rite Aid Corp